5Mu L.Feng SS.A novel controlled release formulation for the anti- cancer drug paclitaxel (Taxol):PLGA nanoparticles containing vitamin E TPGS[J].J Control Realease, 2003,86( 1 ) : 33-48.
6Gao L,Zhang DR,Chen MH,et al.Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions [J].Int J Pharm,2008,355(1-2):321-327.
3Gopferich A. Mechanisms of polymer degradation and erosion[J]. Biomaterials, 1996, 17(2):103.
4Leadley SR, Davies MC, Ribeiro CC, et al. Investigation of the dissolution of the bioceramic hydroxyapatite in the presence of titanium ions using ToF-SIMS and XPS[J]. Biomaterials, 1997, 18(4):311.
5Brem H, Mahaley MS Jr, Vick NA, et al. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas[J]. J Neurosurg, 1991, 74(3):441.
6Mathiowitz E, Jacob JS, Jong YS, et al. Biologically erodable microspheres as potential oral drug delivery systems[J]. Nature, 1997, 386(6623):410.
7Sintzel MB, Heller J, Ng SY, et al. In vitro drug release from self-catalyzed poly (ortho ester): case study of 5-fluorouracil[J]. J Control Release, 1998, 55(2-3):213.
8Damge C,Hillaire-Buys D,Puech R,et al. Effects of orally administered insulin nanocapsules in normal and diabetic dogs[J]. Diab Nutr Metab,1995,8(1):3.
9Kim YI, Fluckiger L, Hoffman M, et al. The antihy-pertensive effect of orally administered nifedipine-loaded nanoparticles in spontaneously hypertensive rats[J]. Br J Pharmacol, 1997, 120:399.
10Yoo HS, Lee KH, Oh JE, et al. In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates[J]. J Control Release, 2000, 68(3):419.
